{"status": "Succeeded", "recognitionResults": [{"page": 1, "clockwiseOrientation": 0.12, "width": 2201, "height": 1738, "unit": "pixel", "lines": [{"boundingBox": [215, 189, 1022, 190, 1021, 265, 214, 264], "text": "Actos Plan Overview", "words": [{"boundingBox": [225, 192, 443, 191, 443, 266, 224, 263], "text": "Actos"}, {"boundingBox": [466, 191, 633, 190, 634, 267, 466, 266], "text": "Plan"}, {"boundingBox": [666, 190, 1005, 192, 1006, 265, 666, 267], "text": "Overview"}]}, {"boundingBox": [228, 382, 607, 383, 606, 420, 227, 418], "text": "Issues/Uncertainties", "words": [{"boundingBox": [231, 384, 606, 385, 607, 421, 230, 420], "text": "Issues/Uncertainties"}]}, {"boundingBox": [229, 426, 542, 425, 543, 461, 230, 462], "text": "Competitive Threats", "words": [{"boundingBox": [235, 427, 426, 427, 424, 461, 232, 462], "text": "Competitive"}, {"boundingBox": [435, 427, 542, 429, 541, 460, 433, 461], "text": "Threats"}]}, {"boundingBox": [1025, 388, 1321, 390, 1320, 429, 1024, 427], "text": "Strategic Intent:", "words": [{"boundingBox": [1031, 389, 1192, 390, 1191, 428, 1031, 428], "text": "Strategic"}, {"boundingBox": [1199, 390, 1320, 391, 1319, 429, 1199, 428], "text": "Intent:"}]}, {"boundingBox": [324, 465, 624, 464, 625, 503, 325, 504], "text": "Avandamet 4/1000", "words": [{"boundingBox": [325, 468, 508, 465, 508, 502, 325, 504], "text": "Avandamet"}, {"boundingBox": [515, 465, 624, 466, 625, 504, 516, 503], "text": "4/1000"}]}, {"boundingBox": [1022, 431, 1705, 432, 1704, 468, 1021, 467], "text": "Establish Actos as the \"best oral\" anti-diabetic", "words": [{"boundingBox": [1026, 434, 1160, 435, 1162, 466, 1028, 464], "text": "Establish"}, {"boundingBox": [1168, 435, 1253, 435, 1254, 468, 1170, 467], "text": "Actos"}, {"boundingBox": [1259, 435, 1296, 435, 1298, 468, 1260, 468], "text": "as"}, {"boundingBox": [1302, 435, 1351, 435, 1353, 468, 1304, 468], "text": "the"}, {"boundingBox": [1357, 435, 1436, 435, 1437, 468, 1359, 468], "text": "\"best"}, {"boundingBox": [1442, 435, 1513, 434, 1514, 468, 1443, 468], "text": "oral\""}, {"boundingBox": [1519, 434, 1700, 432, 1701, 467, 1520, 468], "text": "anti-diabetic"}]}, {"boundingBox": [1024, 470, 1751, 469, 1752, 505, 1025, 505], "text": "medication in treating Insulin Resistance through", "words": [{"boundingBox": [1025, 473, 1187, 473, 1189, 505, 1027, 504], "text": "medication"}, {"boundingBox": [1195, 473, 1222, 472, 1224, 505, 1197, 505], "text": "in"}, {"boundingBox": [1239, 472, 1351, 472, 1353, 506, 1241, 505], "text": "treating"}, {"boundingBox": [1359, 472, 1456, 472, 1459, 506, 1361, 506], "text": "Insulin"}, {"boundingBox": [1463, 472, 1631, 471, 1633, 506, 1465, 506], "text": "Resistance"}, {"boundingBox": [1637, 471, 1749, 470, 1751, 505, 1639, 506], "text": "through"}]}, {"boundingBox": [322, 504, 679, 505, 678, 544, 321, 543], "text": "New Merck PPAR (05)", "words": [{"boundingBox": [325, 505, 394, 506, 393, 544, 324, 543], "text": "New"}, {"boundingBox": [404, 506, 504, 506, 504, 545, 403, 544], "text": "Merck"}, {"boundingBox": [511, 506, 607, 505, 608, 545, 511, 545], "text": "PPAR"}, {"boundingBox": [617, 505, 678, 505, 679, 545, 618, 545], "text": "(05)"}]}, {"boundingBox": [1029, 510, 1840, 507, 1841, 542, 1029, 545], "text": "sustained glycemic control and reduced cardiovascular", "words": [{"boundingBox": [1029, 510, 1170, 510, 1170, 545, 1030, 545], "text": "sustained"}, {"boundingBox": [1176, 510, 1308, 509, 1308, 545, 1177, 545], "text": "glycemic"}, {"boundingBox": [1315, 509, 1418, 509, 1419, 544, 1315, 545], "text": "control"}, {"boundingBox": [1425, 509, 1481, 509, 1481, 544, 1426, 544], "text": "and"}, {"boundingBox": [1488, 509, 1612, 509, 1612, 543, 1488, 544], "text": "reduced"}, {"boundingBox": [1619, 509, 1840, 508, 1840, 542, 1619, 543], "text": "cardiovascular"}]}, {"boundingBox": [1022, 547, 1090, 549, 1087, 581, 1023, 579], "text": "risk.", "words": [{"boundingBox": [1026, 547, 1088, 548, 1087, 580, 1025, 579], "text": "risk."}]}, {"boundingBox": [225, 583, 759, 587, 758, 658, 224, 653], "text": "Other Lilly Drugs", "words": [{"boundingBox": [233, 586, 409, 586, 406, 652, 229, 651], "text": "Other"}, {"boundingBox": [422, 586, 560, 587, 557, 654, 419, 652], "text": "Lilly"}, {"boundingBox": [573, 587, 757, 588, 755, 659, 570, 654], "text": "Drugs"}]}, {"boundingBox": [1024, 597, 1474, 600, 1473, 642, 1023, 638], "text": "Critical Success Factors", "words": [{"boundingBox": [1027, 598, 1160, 599, 1161, 639, 1028, 640], "text": "Critical"}, {"boundingBox": [1169, 599, 1324, 601, 1325, 640, 1169, 639], "text": "Success"}, {"boundingBox": [1333, 601, 1474, 602, 1475, 642, 1333, 640], "text": "Factors"}]}, {"boundingBox": [1026, 639, 1864, 641, 1863, 681, 1025, 680], "text": "> TZD's are prescribed earlier in the treatment of Type 2", "words": [{"boundingBox": [1028, 643, 1055, 643, 1055, 679, 1028, 679], "text": ">"}, {"boundingBox": [1066, 643, 1155, 644, 1154, 679, 1067, 679], "text": "TZD's"}, {"boundingBox": [1162, 644, 1212, 645, 1212, 679, 1162, 679], "text": "are"}, {"boundingBox": [1219, 645, 1376, 646, 1376, 680, 1219, 679], "text": "prescribed"}, {"boundingBox": [1383, 646, 1476, 646, 1475, 680, 1383, 680], "text": "earlier"}, {"boundingBox": [1483, 646, 1512, 645, 1511, 680, 1483, 680], "text": "in"}, {"boundingBox": [1519, 645, 1569, 645, 1568, 680, 1518, 680], "text": "the"}, {"boundingBox": [1576, 645, 1719, 643, 1718, 681, 1575, 680], "text": "treatment"}, {"boundingBox": [1726, 643, 1759, 643, 1758, 681, 1725, 681], "text": "of"}, {"boundingBox": [1766, 643, 1838, 642, 1837, 682, 1765, 681], "text": "Type"}, {"boundingBox": [1845, 641, 1864, 641, 1863, 682, 1844, 682], "text": "2"}]}, {"boundingBox": [236, 704, 756, 707, 755, 744, 235, 741], "text": "Contract negotiations in progress", "words": [{"boundingBox": [236, 705, 369, 706, 369, 742, 236, 740], "text": "Contract"}, {"boundingBox": [376, 706, 572, 707, 571, 743, 376, 742], "text": "negotiations"}, {"boundingBox": [579, 707, 609, 708, 608, 744, 578, 743], "text": "in"}, {"boundingBox": [616, 708, 756, 707, 755, 744, 615, 744], "text": "progress"}]}, {"boundingBox": [1046, 683, 1185, 686, 1184, 718, 1045, 714], "text": "Diabetes", "words": [{"boundingBox": [1048, 683, 1184, 687, 1186, 716, 1048, 716], "text": "Diabetes"}]}, {"boundingBox": [1024, 731, 1786, 734, 1785, 774, 1023, 771], "text": ">Actos is the first TZD prescribed (vs. Avandia) for", "words": [{"boundingBox": [1026, 733, 1143, 735, 1144, 771, 1027, 769], "text": ">Actos", "confidence": "Low"}, {"boundingBox": [1150, 735, 1176, 735, 1177, 771, 1151, 771], "text": "is"}, {"boundingBox": [1184, 735, 1231, 736, 1232, 772, 1184, 771], "text": "the"}, {"boundingBox": [1238, 736, 1298, 736, 1298, 772, 1239, 772], "text": "first"}, {"boundingBox": [1305, 736, 1367, 737, 1367, 773, 1305, 772], "text": "TZD"}, {"boundingBox": [1374, 737, 1532, 737, 1531, 773, 1374, 773], "text": "prescribed"}, {"boundingBox": [1539, 737, 1594, 736, 1593, 773, 1538, 773], "text": "(vs."}, {"boundingBox": [1601, 736, 1732, 735, 1731, 773, 1600, 773], "text": "Avandia)"}, {"boundingBox": [1739, 735, 1784, 734, 1783, 773, 1738, 773], "text": "for"}]}, {"boundingBox": [1044, 774, 1488, 776, 1487, 810, 1043, 809], "text": "patients with Type 2 Diabetes.", "words": [{"boundingBox": [1048, 776, 1168, 776, 1168, 810, 1049, 809], "text": "patients"}, {"boundingBox": [1174, 776, 1236, 776, 1236, 810, 1175, 810], "text": "with"}, {"boundingBox": [1244, 776, 1317, 776, 1317, 810, 1245, 810], "text": "Type"}, {"boundingBox": [1323, 776, 1344, 776, 1345, 810, 1324, 810], "text": "2"}, {"boundingBox": [1351, 776, 1487, 776, 1488, 810, 1352, 810], "text": "Diabetes."}]}, {"boundingBox": [226, 865, 677, 867, 676, 906, 225, 903], "text": "Strengths/Opportunities", "words": [{"boundingBox": [233, 866, 676, 870, 673, 906, 235, 905], "text": "Strengths/Opportunities"}]}, {"boundingBox": [1028, 866, 1283, 864, 1284, 902, 1029, 903], "text": "Key Priorities", "words": [{"boundingBox": [1029, 866, 1101, 867, 1101, 904, 1029, 903], "text": "Key"}, {"boundingBox": [1108, 867, 1279, 865, 1281, 902, 1109, 904], "text": "Priorities"}]}, {"boundingBox": [234, 905, 989, 906, 988, 944, 233, 943], "text": "TL's believe TZDs will provide improved durability &", "words": [{"boundingBox": [234, 906, 293, 908, 295, 943, 237, 942], "text": "TL's"}, {"boundingBox": [300, 908, 411, 910, 413, 944, 303, 943], "text": "believe"}, {"boundingBox": [419, 910, 499, 911, 501, 944, 420, 944], "text": "TZDs"}, {"boundingBox": [506, 911, 554, 911, 555, 945, 508, 944], "text": "will"}, {"boundingBox": [561, 911, 672, 911, 673, 945, 562, 945], "text": "provide"}, {"boundingBox": [679, 911, 823, 909, 824, 945, 680, 945], "text": "improved"}, {"boundingBox": [831, 909, 966, 906, 965, 944, 831, 945], "text": "durability"}, {"boundingBox": [973, 906, 989, 906, 989, 944, 972, 944], "text": "&"}]}, {"boundingBox": [1022, 908, 1825, 906, 1825, 942, 1023, 944], "text": "Drive a thoughtful, robust, and coherent set of medical", "words": [{"boundingBox": [1028, 910, 1108, 910, 1109, 943, 1029, 943], "text": "Drive"}, {"boundingBox": [1114, 910, 1134, 910, 1135, 943, 1115, 943], "text": "a"}, {"boundingBox": [1140, 910, 1296, 910, 1297, 943, 1141, 943], "text": "thoughtful,"}, {"boundingBox": [1303, 910, 1411, 910, 1411, 943, 1303, 943], "text": "robust,"}, {"boundingBox": [1418, 910, 1474, 910, 1474, 943, 1418, 943], "text": "and"}, {"boundingBox": [1481, 910, 1613, 909, 1612, 943, 1480, 943], "text": "coherent"}, {"boundingBox": [1619, 909, 1667, 908, 1666, 943, 1619, 943], "text": "set"}, {"boundingBox": [1674, 908, 1702, 908, 1701, 943, 1673, 943], "text": "of"}, {"boundingBox": [1708, 908, 1823, 906, 1822, 942, 1707, 942], "text": "medical"}]}, {"boundingBox": [249, 947, 842, 945, 843, 980, 250, 982], "text": "b-cell preservation and reduced CV risk", "words": [{"boundingBox": [255, 948, 336, 949, 336, 982, 255, 981], "text": "b-cell"}, {"boundingBox": [343, 949, 527, 950, 528, 982, 343, 982], "text": "preservation"}, {"boundingBox": [536, 950, 591, 949, 591, 982, 536, 982], "text": "and"}, {"boundingBox": [597, 949, 723, 948, 723, 982, 598, 982], "text": "reduced"}, {"boundingBox": [729, 948, 775, 947, 776, 981, 730, 981], "text": "CV"}, {"boundingBox": [782, 947, 839, 946, 840, 981, 783, 981], "text": "risk"}]}, {"boundingBox": [1047, 945, 1735, 944, 1736, 980, 1048, 981], "text": "studies to document the full benefits of ACTOS", "words": [{"boundingBox": [1050, 947, 1156, 948, 1157, 980, 1050, 978], "text": "studies"}, {"boundingBox": [1162, 948, 1193, 949, 1193, 980, 1163, 980], "text": "to"}, {"boundingBox": [1203, 949, 1348, 949, 1349, 982, 1204, 981], "text": "document"}, {"boundingBox": [1354, 949, 1401, 949, 1402, 982, 1355, 982], "text": "the"}, {"boundingBox": [1409, 949, 1454, 949, 1455, 982, 1410, 982], "text": "full"}, {"boundingBox": [1460, 948, 1581, 947, 1582, 981, 1461, 982], "text": "benefits"}, {"boundingBox": [1587, 947, 1616, 947, 1616, 981, 1588, 981], "text": "of"}, {"boundingBox": [1622, 947, 1734, 945, 1735, 980, 1622, 981], "text": "ACTOS"}]}, {"boundingBox": [233, 998, 855, 999, 854, 1036, 232, 1035], "text": "Supporting studies on TZDs are underway", "words": [{"boundingBox": [236, 1000, 396, 999, 397, 1036, 236, 1035], "text": "Supporting"}, {"boundingBox": [403, 999, 511, 999, 512, 1036, 404, 1036], "text": "studies"}, {"boundingBox": [518, 999, 556, 999, 558, 1036, 519, 1036], "text": "on"}, {"boundingBox": [566, 999, 646, 999, 647, 1036, 567, 1036], "text": "TZDs"}, {"boundingBox": [653, 999, 701, 1000, 702, 1036, 654, 1036], "text": "are"}, {"boundingBox": [708, 1000, 852, 1002, 854, 1035, 709, 1036], "text": "underway"}]}, {"boundingBox": [1024, 999, 1617, 1003, 1616, 1037, 1023, 1034], "text": "Keep opinion leaders at the cutting edge", "words": [{"boundingBox": [1026, 1000, 1108, 1001, 1109, 1035, 1028, 1035], "text": "Keep"}, {"boundingBox": [1114, 1001, 1221, 1003, 1222, 1035, 1116, 1035], "text": "opinion"}, {"boundingBox": [1228, 1003, 1341, 1003, 1342, 1036, 1229, 1035], "text": "leaders"}, {"boundingBox": [1347, 1003, 1377, 1003, 1378, 1036, 1349, 1036], "text": "at"}, {"boundingBox": [1384, 1003, 1433, 1004, 1435, 1036, 1385, 1036], "text": "the"}, {"boundingBox": [1440, 1004, 1540, 1003, 1541, 1037, 1442, 1036], "text": "cutting"}, {"boundingBox": [1547, 1003, 1614, 1003, 1616, 1038, 1548, 1037], "text": "edge"}]}, {"boundingBox": [233, 1048, 972, 1050, 971, 1091, 232, 1090], "text": "ACTOS has a superior lipid profile (v. Avandia and", "words": [{"boundingBox": [236, 1050, 348, 1052, 347, 1089, 235, 1087], "text": "ACTOS"}, {"boundingBox": [355, 1052, 412, 1052, 412, 1090, 355, 1089], "text": "has"}, {"boundingBox": [419, 1052, 441, 1052, 440, 1090, 419, 1090], "text": "a"}, {"boundingBox": [448, 1052, 567, 1053, 567, 1091, 448, 1090], "text": "superior"}, {"boundingBox": [574, 1053, 636, 1053, 636, 1091, 574, 1091], "text": "lipid"}, {"boundingBox": [643, 1053, 736, 1052, 736, 1091, 643, 1091], "text": "profile"}, {"boundingBox": [743, 1052, 779, 1052, 779, 1091, 743, 1091], "text": "(v."}, {"boundingBox": [786, 1052, 910, 1051, 910, 1090, 786, 1091], "text": "Avandia"}, {"boundingBox": [917, 1051, 971, 1050, 972, 1089, 917, 1090], "text": "and"}]}, {"boundingBox": [1031, 1054, 1810, 1054, 1809, 1091, 1030, 1090], "text": "Fund CME and other initiatives that allow the opinion", "words": [{"boundingBox": [1031, 1054, 1107, 1056, 1107, 1091, 1031, 1091], "text": "Fund"}, {"boundingBox": [1114, 1056, 1187, 1058, 1188, 1092, 1114, 1091], "text": "CME"}, {"boundingBox": [1197, 1058, 1254, 1059, 1254, 1092, 1197, 1092], "text": "and"}, {"boundingBox": [1261, 1059, 1337, 1059, 1338, 1092, 1261, 1092], "text": "other"}, {"boundingBox": [1344, 1059, 1482, 1060, 1483, 1091, 1345, 1092], "text": "initiatives"}, {"boundingBox": [1489, 1060, 1548, 1060, 1549, 1091, 1490, 1091], "text": "that"}, {"boundingBox": [1555, 1060, 1631, 1059, 1632, 1090, 1556, 1091], "text": "allow"}, {"boundingBox": [1641, 1059, 1688, 1059, 1690, 1090, 1642, 1090], "text": "the"}, {"boundingBox": [1695, 1059, 1807, 1057, 1808, 1088, 1697, 1089], "text": "opinion"}]}, {"boundingBox": [254, 1090, 354, 1092, 353, 1124, 253, 1123], "text": "others)", "words": [{"boundingBox": [256, 1091, 353, 1092, 354, 1124, 257, 1123], "text": "others)"}]}, {"boundingBox": [1039, 1093, 1874, 1094, 1873, 1130, 1038, 1129], "text": "leaders to \"spread the word\" ahead of our evolving label", "words": [{"boundingBox": [1048, 1095, 1159, 1096, 1160, 1129, 1049, 1128], "text": "leaders"}, {"boundingBox": [1165, 1096, 1196, 1096, 1197, 1129, 1166, 1129], "text": "to"}, {"boundingBox": [1202, 1096, 1317, 1097, 1319, 1130, 1203, 1129], "text": "\"spread"}, {"boundingBox": [1324, 1097, 1374, 1097, 1375, 1130, 1325, 1130], "text": "the"}, {"boundingBox": [1380, 1097, 1467, 1097, 1469, 1130, 1382, 1130], "text": "word\""}, {"boundingBox": [1474, 1097, 1567, 1097, 1569, 1130, 1475, 1130], "text": "ahead"}, {"boundingBox": [1574, 1097, 1604, 1097, 1606, 1130, 1575, 1130], "text": "of"}, {"boundingBox": [1611, 1097, 1663, 1096, 1664, 1130, 1612, 1130], "text": "our"}, {"boundingBox": [1669, 1096, 1791, 1095, 1792, 1129, 1671, 1130], "text": "evolving"}, {"boundingBox": [1797, 1095, 1871, 1094, 1873, 1128, 1799, 1129], "text": "label"}]}, {"boundingBox": [233, 1140, 986, 1142, 985, 1180, 232, 1178], "text": "New lipid standards place more importance on lipid", "words": [{"boundingBox": [233, 1142, 299, 1143, 300, 1178, 233, 1178], "text": "New"}, {"boundingBox": [306, 1143, 370, 1144, 370, 1178, 307, 1178], "text": "lipid"}, {"boundingBox": [377, 1144, 524, 1146, 524, 1178, 377, 1178], "text": "standards"}, {"boundingBox": [531, 1146, 611, 1146, 611, 1179, 531, 1178], "text": "place"}, {"boundingBox": [618, 1146, 696, 1146, 696, 1179, 618, 1179], "text": "more"}, {"boundingBox": [703, 1146, 873, 1144, 874, 1180, 704, 1179], "text": "importance"}, {"boundingBox": [880, 1144, 916, 1143, 916, 1180, 881, 1180], "text": "on"}, {"boundingBox": [923, 1143, 984, 1142, 985, 1181, 923, 1180], "text": "lipid"}]}, {"boundingBox": [1050, 1133, 1149, 1135, 1147, 1168, 1051, 1167], "text": "claims", "words": [{"boundingBox": [1052, 1132, 1147, 1133, 1146, 1167, 1051, 1166], "text": "claims"}]}, {"boundingBox": [253, 1185, 618, 1186, 618, 1215, 252, 1214], "text": "management in diabetes", "words": [{"boundingBox": [255, 1187, 452, 1186, 454, 1215, 256, 1215], "text": "management"}, {"boundingBox": [457, 1186, 483, 1186, 485, 1215, 459, 1215], "text": "in"}, {"boundingBox": [499, 1186, 616, 1187, 618, 1216, 501, 1215], "text": "diabetes"}]}, {"boundingBox": [1027, 1186, 1878, 1187, 1877, 1225, 1026, 1224], "text": "Drive behavior change with physicians via our sales force.", "words": [{"boundingBox": [1029, 1186, 1106, 1186, 1108, 1224, 1031, 1224], "text": "Drive"}, {"boundingBox": [1114, 1186, 1243, 1187, 1244, 1225, 1115, 1224], "text": "behavior"}, {"boundingBox": [1251, 1187, 1360, 1188, 1361, 1225, 1252, 1225], "text": "change"}, {"boundingBox": [1368, 1188, 1430, 1188, 1431, 1225, 1369, 1225], "text": "with"}, {"boundingBox": [1437, 1188, 1594, 1188, 1595, 1225, 1438, 1225], "text": "physicians"}, {"boundingBox": [1602, 1188, 1647, 1188, 1647, 1225, 1602, 1225], "text": "via"}, {"boundingBox": [1654, 1188, 1704, 1188, 1704, 1225, 1655, 1225], "text": "our"}, {"boundingBox": [1711, 1188, 1789, 1188, 1789, 1225, 1712, 1225], "text": "sales"}, {"boundingBox": [1796, 1188, 1878, 1188, 1878, 1224, 1796, 1225], "text": "force."}]}, {"boundingBox": [233, 1235, 683, 1237, 683, 1272, 232, 1270], "text": "Pre-diabetes and DPP Results", "words": [{"boundingBox": [233, 1237, 425, 1239, 425, 1270, 233, 1269], "text": "Pre-diabetes"}, {"boundingBox": [432, 1239, 489, 1239, 489, 1270, 432, 1270], "text": "and"}, {"boundingBox": [495, 1239, 563, 1239, 563, 1271, 495, 1270], "text": "DPP"}, {"boundingBox": [573, 1239, 683, 1237, 683, 1272, 573, 1271], "text": "Results"}]}, {"boundingBox": [1023, 1241, 1638, 1243, 1637, 1282, 1023, 1281], "text": "Keep managed care from being a barrier.", "words": [{"boundingBox": [1027, 1243, 1106, 1244, 1105, 1281, 1026, 1281], "text": "Keep"}, {"boundingBox": [1114, 1244, 1254, 1245, 1254, 1281, 1113, 1281], "text": "managed"}, {"boundingBox": [1262, 1245, 1326, 1246, 1326, 1281, 1262, 1281], "text": "care"}, {"boundingBox": [1334, 1246, 1398, 1246, 1398, 1281, 1334, 1281], "text": "from"}, {"boundingBox": [1410, 1246, 1495, 1246, 1495, 1281, 1411, 1281], "text": "being"}, {"boundingBox": [1503, 1246, 1520, 1246, 1521, 1281, 1503, 1281], "text": "a"}, {"boundingBox": [1528, 1246, 1636, 1245, 1637, 1281, 1529, 1281], "text": "barrier."}]}, {"boundingBox": [231, 1288, 997, 1289, 996, 1325, 230, 1324], "text": "Window of opportunity exists - no new TZD entrants", "words": [{"boundingBox": [233, 1290, 347, 1291, 349, 1324, 235, 1322], "text": "Window"}, {"boundingBox": [360, 1291, 390, 1291, 392, 1324, 362, 1324], "text": "of"}, {"boundingBox": [397, 1291, 565, 1292, 566, 1325, 398, 1324], "text": "opportunity"}, {"boundingBox": [571, 1292, 657, 1292, 659, 1325, 573, 1325], "text": "exists"}, {"boundingBox": [663, 1292, 676, 1292, 678, 1325, 665, 1325], "text": "-"}, {"boundingBox": [683, 1292, 724, 1292, 725, 1325, 684, 1325], "text": "no"}, {"boundingBox": [730, 1292, 788, 1291, 790, 1325, 732, 1325], "text": "new"}, {"boundingBox": [803, 1291, 861, 1290, 863, 1325, 805, 1325], "text": "TZD"}, {"boundingBox": [874, 1290, 995, 1289, 996, 1324, 876, 1325], "text": "entrants"}]}, {"boundingBox": [253, 1328, 553, 1329, 553, 1361, 252, 1360], "text": "to market until 2005.", "words": [{"boundingBox": [253, 1329, 282, 1329, 284, 1360, 255, 1361], "text": "to"}, {"boundingBox": [288, 1329, 395, 1330, 397, 1360, 291, 1360], "text": "market"}, {"boundingBox": [402, 1330, 467, 1330, 468, 1360, 404, 1360], "text": "until"}, {"boundingBox": [473, 1330, 550, 1329, 552, 1362, 475, 1360], "text": "2005."}]}, {"boundingBox": [236, 1451, 321, 1452, 320, 1475, 235, 1474], "text": "<AUTO>", "words": [{"boundingBox": [236, 1453, 316, 1452, 317, 1475, 237, 1474], "text": "<AUTO>", "confidence": "Low"}]}, {"boundingBox": [103, 1600, 552, 1599, 553, 1629, 104, 1630], "text": "Confidential - Subject to Protective Order", "words": [{"boundingBox": [104, 1600, 227, 1603, 228, 1630, 104, 1630], "text": "Confidential"}, {"boundingBox": [233, 1603, 249, 1603, 249, 1630, 234, 1630], "text": "-"}, {"boundingBox": [255, 1603, 335, 1603, 335, 1630, 255, 1630], "text": "Subject"}, {"boundingBox": [341, 1603, 362, 1603, 363, 1629, 341, 1630], "text": "to"}, {"boundingBox": [368, 1603, 478, 1602, 479, 1629, 369, 1629], "text": "Protective"}, {"boundingBox": [484, 1602, 552, 1601, 553, 1629, 484, 1629], "text": "Order"}]}, {"boundingBox": [1741, 1601, 2017, 1601, 2016, 1629, 1740, 1628], "text": "LLY-HOVENR-00001911", "words": [{"boundingBox": [1743, 1601, 2015, 1602, 2017, 1629, 1745, 1630], "text": "LLY-HOVENR-00001911"}]}, {"boundingBox": [1743, 1633, 2109, 1634, 2108, 1667, 1742, 1666], "text": "Produced in MDL on 02/27/13", "words": [{"boundingBox": [1745, 1635, 1863, 1636, 1863, 1664, 1745, 1666], "text": "Produced"}, {"boundingBox": [1869, 1636, 1891, 1636, 1891, 1663, 1869, 1664], "text": "in"}, {"boundingBox": [1897, 1636, 1955, 1635, 1955, 1664, 1897, 1663], "text": "MDL"}, {"boundingBox": [1961, 1635, 1993, 1635, 1993, 1664, 1961, 1664], "text": "on"}, {"boundingBox": [1999, 1635, 2109, 1634, 2109, 1668, 1999, 1664], "text": "02/27/13"}]}, {"boundingBox": [632, 1693, 1569, 1691, 1570, 1733, 633, 1734], "text": "Source: https://www.induposescoots.ucsf.edu/docs/ynjf0226", "words": [{"boundingBox": [636, 1695, 748, 1696, 748, 1732, 636, 1729], "text": "Source:"}, {"boundingBox": [755, 1696, 1568, 1692, 1570, 1730, 755, 1732], "text": "https://www.induposescoots.ucsf.edu/docs/ynjf0226", "confidence": "Low"}]}]}]}